Results 81 to 90 of about 5,126 (291)

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

Self-Contrastive Forward-Forward algorithm

open access: yesNature Communications
Agents that operate autonomously benefit from lifelong learning capabilities. However, compatible training algorithms must comply with the decentralized nature of these systems, which imposes constraints on both the parameter counts and the computational resources. The Forward-Forward (FF) algorithm is one of these.
Chen, Xing   +3 more
openaire   +5 more sources

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Freight forwarder

open access: yes, 2013
Taşıma işleri komisyoncusu adını taşıyan bu çalışmada, 6102 sayılı Türk Ticaret Kanunu'nun, 6762 sayılı eski Türk Ticaret Kanunu'ndan farklı olarak ayrı bir kitap hâline getirilen ve hazırlanmasında mehaz oluşturan 25/06/1998 tarihli Alman Taşıma Hukuku ...
Akdeniz, Umut
core  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Construction of forwarder trailer

open access: yes, 2017
Diplomová práce se zabývá konstrukčním návrhem a následnou realizací vyvážecího vleku. V práci jsou popsány druhy vyvážecích vleků a jejich hlavní konstrukční celky. Vyvážecí vlek bude konstruován podle daných parametrů.
Černý, Miroslav
core  

Análise técnica e econômica do forwarder em três subsistemas de colheita de florestas de eucalipto Technical and economic analysis of a forwarder under three eucalyptus forest harvest subsystems

open access: yesRevista Árvore, 2004
O objetivo deste trabalho foi avaliar técnica e economicamente o forwarder em três subsistemas de colheita em florestas de eucalipto. A análise técnica englobou um estudo de tempos e movimentos e de produtividade.
Luciano José Minette   +4 more
doaj   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

open access: yesMolecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang   +9 more
wiley   +1 more source

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy